Conformational control in structure-based drug design

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Design

Background:

• Structure-based drug design aims to create molecules complementary to target binding pockets.
• A key challenge is ensuring designed ligands maintain favorable low-energy conformations both within and outside the binding site.
• Computational methods and analysis of existing structural data are crucial for predicting and controlling molecular conformations.

Purpose of the Study:

• To review the applications of conformational control in structure-based drug design.
• To highlight conformational features applicable to broader drug discovery programs.
• To provide insights from recent medicinal chemistry literature.

Main Methods:

• Utilizing computational chemistry techniques.
• Analyzing conformational preferences of small molecules from the Protein Data Bank (PDB) and Cambridge Structural Database (CSD).
• Reviewing selected examples from recent medicinal chemistry literature.

Main Results:

• Demonstrated the importance of conformational control in structure-based drug design.
• Identified intriguing conformational features with potential for application in other drug discovery projects.
• Provided a review of current strategies and examples.

Conclusions:

• Conformational control is essential for successful structure-based drug design.
• Leveraging computational chemistry and structural databases aids in predicting and achieving desired ligand conformations.
• The reviewed conformational features offer valuable strategies for future drug discovery efforts.